Anti-TM4SF5 chimeric and humanized monoclonal antibodies were generated and found to efficiently suppress tumor growth in nude mice bearing liver or colon cancer xenografts, without generating general toxicity, suggesting that these antibodies have potential as novel therapeutic agents. This evidence concerns the gene TM4SF5 and neoplasm.